Reviewer Guidelines

Reviewer Guidelines

The Journal of Pharmacovigilance and Drug Research (JPADR) values the important contribution of peer reviewers in maintaining scientific quality, ethical standards, and publication integrity.

Peer review is a fundamental component of scholarly publishing and helps ensure that published research is scientifically sound, ethically compliant, methodologically rigorous, relevant to the journal scope, and clearly presented. These guidelines describe the expectations, responsibilities, and ethical standards for reviewers participating in the JPADR peer-review process.

Peer Review Ethics Framework

JPADR follows internationally recognized recommendations and best practices for ethical peer review and responsible scholarly publishing. Reviewers are expected to uphold the highest standards of scientific integrity, confidentiality, fairness, and professionalism throughout the review process.

Committee on Publication Ethics (COPE)

Ethical guidance for editors, reviewers, publishers, and authors.

International Committee of Medical Journal Editors (ICMJE)

Recommendations for peer review, editorial conduct, and biomedical publishing.

World Association of Medical Editors (WAME)

Global best practices supporting responsible editorial and peer-review standards.

1. Purpose of Peer Review

Peer review serves as an essential quality assurance mechanism that supports scientific excellence and assists editors in making informed publication decisions.

Peer review aims to:

  • Evaluate the scientific quality of submitted manuscripts.
  • Improve manuscript clarity, accuracy, and overall rigor.
  • Identify methodological limitations and potential weaknesses.
  • Ensure compliance with applicable ethical standards.
  • Support objective editorial decision-making.
  • Enhance the reliability and credibility of published research.
Reviewer Contribution

Constructive reviewer comments help authors strengthen their manuscripts while providing editors with balanced scientific assessments that facilitate fair and transparent publication decisions.

2. Type of Peer Review

JPADR follows a Double-Blind Peer Review process designed to promote fairness, objectivity, and impartial scientific evaluation.

Under this system:

  • Reviewer identities are not disclosed to authors.
  • Author identities are not disclosed to reviewers.
  • Editorial confidentiality is maintained throughout the review process.
  • Scientific merit remains the primary basis for editorial assessment.
Objective

Maintaining reviewer and author anonymity helps minimize bias and promotes independent, evidence-based manuscript evaluation.

3. Reviewer Eligibility and Selection

Reviewers are selected according to their expertise, academic qualifications, professional experience, and ability to provide objective scientific evaluation.

Reviewer selection may consider:

  • Subject-specific expertise.
  • Academic qualifications.
  • Research experience.
  • Publication record.
  • Previous peer-review performance.
  • Professional reputation.

Reviewers may include:

  • Researchers.
  • Academicians.
  • Clinicians.
  • Pharmacovigilance experts.
  • Healthcare professionals.
  • Subject specialists.

The journal may verify reviewer credentials, institutional affiliations, and professional expertise before assigning manuscripts for review.

4. Reviewer Invitation Process

Upon receiving an invitation to review, prospective reviewers should carefully evaluate whether they are able to undertake the assignment responsibly and within the requested timeframe.

Reviewers should:

  • Assess whether the manuscript aligns with their area of expertise.
  • Confirm availability to complete the review within the requested timeline.
  • Disclose any actual or potential conflicts of interest.
  • Accept or decline the invitation promptly.
Timely Response

Reviewers who are unable to complete a timely review are encouraged to decline the invitation promptly to prevent unnecessary delays in the editorial process.

5. Reviewer Responsibilities

Reviewers play a vital role in maintaining the scientific quality and integrity of manuscripts considered for publication.

Reviewers are expected to:

  • Provide objective, balanced, and constructive feedback.
  • Maintain strict manuscript confidentiality.
  • Evaluate scientific quality fairly and consistently.
  • Identify potential ethical concerns where applicable.
  • Declare competing interests before undertaking a review.
  • Complete reviews within the agreed timeline.

Reviews should be based solely on scientific merit, methodological quality, ethical compliance, and relevance to the journal's scope, without regard to authors' nationality, institutional affiliation, gender, or personal beliefs.

6. Confidentiality Requirements

All manuscripts submitted to the Journal of Pharmacovigilance and Drug Research (JPADR) for peer review are confidential documents. Reviewers are entrusted with protecting the confidentiality of the manuscript, associated data, and all communications received during the editorial process.

Reviewers must not:

  • Share manuscripts with unauthorized individuals.
  • Discuss manuscript contents outside the editorial process.
  • Use unpublished data or ideas for personal or professional advantage.
  • Retain manuscript copies after completion of the review unless specifically authorized by the journal.
  • Disclose reviewer assignments or editorial communications without permission.
Confidentiality Commitment

Confidentiality obligations continue after completion of the peer-review process and remain applicable even if the manuscript is rejected or withdrawn.

7. Conflict of Interest Disclosure

Reviewers are expected to disclose any actual, potential, or perceived conflicts of interest before accepting a review assignment. Such conflicts may compromise, or reasonably appear to compromise, objective scientific assessment.

Potential conflicts may include:

  • Financial relationships.
  • Institutional affiliations.
  • Academic competition.
  • Personal relationships.
  • Current or recent collaborative relationships with the authors.
Reviewer Obligation

Reviewers with significant competing interests that may affect impartiality should decline the review invitation. If uncertainty exists, reviewers should consult the editorial office before proceeding.

8. Ethical Responsibilities of Reviewers

Reviewers are expected to uphold the highest standards of ethical conduct, professionalism, and scientific integrity throughout the peer-review process.

Reviewers should:

  • Maintain professionalism and objectivity.
  • Respect authors, editors, and editorial staff.
  • Avoid discriminatory, offensive, or inappropriate language.
  • Provide evidence-based and scientifically justified comments.
  • Report suspected ethical concerns confidentially to the editors.

Potential ethical concerns include:

  • Plagiarism.
  • Duplicate or redundant publication.
  • Data fabrication or falsification.
  • Inadequate ethical approval or informed consent.
  • Image manipulation.
  • Citation manipulation or inappropriate referencing.
Reporting Ethical Concerns

Suspected ethical issues should be communicated confidentially through the editorial office. Reviewers should avoid making direct accusations to authors or including confidential allegations within comments intended for authors.

9. Manuscript Evaluation Criteria

Reviewers should evaluate manuscripts comprehensively, objectively, and consistently while considering scientific quality, methodological rigor, and relevance to the journal.

Evaluation may include:

  • Originality and novelty.
  • Scientific significance and contribution.
  • Relevance to the journal's aims and scope.
  • Study design and methodological quality.
  • Appropriateness of statistical analysis.
  • Compliance with ethical standards.
  • Clarity, organization, and quality of writing.
  • Validity and interpretation of conclusions.
  • Adequacy, relevance, and currency of references.
  • Transparency and completeness of reporting.
Objective Assessment

Reviewer recommendations should reflect the overall scientific merit of the manuscript and should not be influenced by personal opinions, institutional affiliations, nationality, gender, or other unrelated factors.

10. Structure of Reviewer Comments

Constructive reviewer reports facilitate editorial decision-making and assist authors in improving the quality of their manuscripts. Reviewer comments should be organized, professional, and scientifically justified.

Reviewer reports are encouraged to include:

  • General comments summarizing the overall assessment.
  • Major concerns affecting scientific validity or interpretation.
  • Minor concerns related to clarity, formatting, or presentation.
  • Specific recommendations for improving the manuscript.

Reviewer comments should be:

  • Constructive.
  • Clear and concise.
  • Professional and respectful.
  • Scientifically justified.
  • Focused on improving the manuscript.
Professional Communication

Reviewer comments should critique the manuscript rather than the authors. Personal criticism, inflammatory language, or disrespectful remarks are not appropriate and may result in editorial intervention.

11. Recommendations Available to Reviewers

Following completion of the scientific assessment, reviewers are requested to provide an overall recommendation regarding the suitability of the manuscript for publication. Reviewer recommendations assist editors in the decision-making process but do not constitute the final editorial decision.

Reviewers may recommend:

  • Accept without Revision – The manuscript is suitable for publication in its current form.
  • Minor Revision – The manuscript requires limited revisions before publication.
  • Major Revision – Substantial revisions are required before the manuscript can be reconsidered.
  • Reject – The manuscript is not suitable for publication in JPADR.
Editorial Authority

Reviewer recommendations are advisory only. Final publication decisions are made by the Editor-in-Chief, handling editors, or other authorized editorial personnel after considering reviewer comments, editorial assessment, and journal policies.

12. Review Timelines

JPADR is committed to providing an efficient, timely, and transparent peer-review process while ensuring rigorous scientific evaluation. Reviewers are encouraged to complete their assessments within the requested timeframe to support timely editorial decisions.

Typical Review Timeline

Stage Estimated Timeline
Reviewer Invitation Response 3–7 days
Peer Review Completion 2–4 weeks
Revision Review 1–3 weeks
Final Editorial Decision 4–6 weeks
Note

Actual review timelines may vary depending on manuscript complexity, reviewer availability, revision requirements, and other editorial considerations.

13. Revised Manuscripts

When reviewing revised submissions, reviewers should assess whether the authors have adequately addressed the comments raised during the initial review while maintaining scientific accuracy and consistency.

Reviewers should:

  • Evaluate whether previous concerns have been addressed appropriately.
  • Review the authors' response document carefully.
  • Identify any unresolved scientific or methodological issues.
  • Provide updated, objective, and evidence-based recommendations.
  • Maintain consistency, fairness, and impartiality throughout re-evaluation.
Consistency in Review

If new concerns arise during revision, reviewers should clearly explain their scientific basis while distinguishing them from issues raised during the original review.

14. Use of Artificial Intelligence by Reviewers

Reviewers must protect manuscript confidentiality when using any digital tools. Confidential manuscript content should never be uploaded to public or unauthorized artificial intelligence (AI) platforms.

If AI tools are used for limited editorial assistance, reviewers remain fully responsible for:

  • Accuracy of the review.
  • Protection of manuscript confidentiality.
  • Compliance with ethical standards.
  • Independent scientific judgment.
  • The final content of reviewer comments.
Responsible AI Use

Artificial intelligence tools must not replace independent scientific evaluation, professional expertise, or reviewer accountability. Reviewer judgment must always remain the basis of editorial recommendations.

15. Reviewer Recognition

JPADR recognizes that peer reviewers make an essential contribution to the quality, integrity, and credibility of scholarly publishing. The journal values their voluntary service and may acknowledge reviewer contributions through appropriate recognition initiatives.

Reviewer recognition may include:

  • Reviewer certificates.
  • Annual reviewer acknowledgements.
  • Reviewer recognition programs.
  • Integration with reviewer recognition platforms, where applicable.
Confidentiality of Reviewer Identity

Reviewer identities remain confidential throughout the editorial process unless explicit consent has been provided by the reviewer and disclosure is consistent with journal policies and applicable ethical standards.

16. Reviewer Misconduct

JPADR expects reviewers to uphold the highest standards of integrity, professionalism, confidentiality, and ethical conduct throughout the peer-review process. Reviewer misconduct may compromise the integrity of scholarly publishing and will be addressed in accordance with the journal's editorial policies and ethical guidelines.

Examples of reviewer misconduct include:

  • Breach of manuscript confidentiality.
  • Failure to disclose actual or potential conflicts of interest.
  • Inappropriate, discriminatory, or unprofessional behavior.
  • Deliberate or unjustified delays in completing reviews.
  • Misuse of confidential manuscript information for personal, academic, or commercial advantage.
  • Submission of biased, intentionally misleading, or unethical reviewer reports.
  • Unauthorized sharing or distribution of manuscript content.
Editorial Action

Where reviewer misconduct is identified or reasonably suspected, JPADR may terminate reviewer assignments, discontinue future collaboration, remove the reviewer from its reviewer database, or take other appropriate editorial actions consistent with applicable publication ethics guidance.

17. Appeals and Reviewer Communication

To preserve the integrity and confidentiality of the peer-review process, all communications concerning manuscripts under review should occur exclusively through the editorial office.

Reviewers should:

  • Communicate only through the journal's editorial system or editorial office.
  • Maintain confidentiality regarding editorial discussions.
  • Avoid direct communication with authors concerning manuscripts under review.
  • Notify editors confidentially if significant concerns arise during the review process.
  • Seek clarification from editors whenever additional information is required.
Editorial Mediation

Any disagreement regarding reviewer comments, editorial decisions, or review procedures should be communicated confidentially to the handling editor or Editor-in-Chief for appropriate consideration.

18. Reviewer Performance Monitoring

JPADR continuously monitors reviewer performance to maintain a high-quality, efficient, and ethical peer-review system. Reviewer evaluations support ongoing editorial quality assurance and continuous process improvement.

Reviewer performance may be evaluated based on:

  • Timeliness of review completion.
  • Scientific quality of reviewer reports.
  • Professionalism and respectful communication.
  • Compliance with confidentiality and ethical standards.
  • Constructiveness, clarity, and usefulness of reviewer comments.

Reviewer performance records may support:

  • Editorial workflow audits.
  • Quality assurance and continuous improvement initiatives.
  • Future reviewer selection and assignment decisions.
  • Reviewer recognition and development programs.
Continuous Quality Improvement

Performance monitoring is intended to strengthen the quality and consistency of peer review while supporting fair, transparent, and evidence-based editorial decision-making.

19. Commitment to Ethical Peer Review

The Journal of Pharmacovigilance and Drug Research (JPADR) is committed to maintaining a rigorous, transparent, and ethical peer-review process that supports scientific excellence and protects the integrity of the scholarly record.

JPADR is committed to:

  • Fair, objective, and unbiased peer review.
  • Editorial transparency and accountability.
  • Reviewer confidentiality and independence.
  • Ethical scholarly communication.
  • Responsible editorial and publication practices.
  • Continuous improvement of peer-review quality.
Our Commitment

High-quality peer review remains one of the cornerstones of credible scientific publishing. JPADR recognizes the invaluable contribution of reviewers in ensuring that published research meets the highest standards of scientific quality, ethical compliance, methodological rigor, and publication integrity.

References

  1. Committee on Publication Ethics (COPE). Ethical Guidelines for Peer Reviewers.
  2. International Committee of Medical Journal Editors (ICMJE). Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals.
  3. World Association of Medical Editors (WAME). Best Practices for Reviewer Responsibilities.
  4. Council of Science Editors (CSE). White Paper on Publication Ethics and Peer Review.

Journal of Pharmacovigilance and Drug Research (JPADR)

Reviewer Guidelines • Ethical Peer Review • Scientific Integrity • Editorial Excellence

© JPADR. All rights reserved.